Sökning: "FoU som tillgång"

Visar resultat 1 - 5 av 11 avhandlingar innehållade orden FoU som tillgång.

  1. 1. Redovisning av utgifter för Forskning och Utveckling : En metodstudie

    Författare :Jan Hemlin; Thomas Polesie; Bent Dreyer; Mittuniversitetet; []
    Nyckelord :SAMHÄLLSVETENSKAP; SOCIAL SCIENCES; Externredovisning; Forskning och Utveckling; FoU; aktivering; FoU som tillgång; regressionsanalys; metodproblem; Business studies; Företagsekonomi; Externredovisning; Forskning och Utveckling; FoU; aktivering; FoU som tillgång; regressionsanalys; metodproblem;

    Sammanfattning : Hur företag redovisar sina investeringar i Forskning och Utveckling (FoU) är inte oväsentlig, eftersom kostnad eller tillgång i affärsredovisningen medför olika finansiella effekter på balans- och resultaträkning. Detta har betydelse för en bedömning av framtida finansiell avkastning och tillväxt för företagen. LÄS MER

  3. 2. Change in the Pharmaceutical Industry : Aspects on Innovation, Entrepreneurship, Openness, and Decision Making

    Författare :Thomas Hedner; Magnus Klofsten; Johan Braet; Mirjam Knockaert; Linköpings universitet; []
    Nyckelord :Pharmaceutical industry; Big Pharma; life sciences; drug discovery; drug development; R D; business model; innovation; closed innovation; open innovation; entrepreneurship; intellectual property; multiple stakeholders; decision making; judgment; uncertainty; go no-go; go no-go recycle; company; SME.; Läkemedelsindustri; Big Pharma; biovetenskap; läkemedelsutveckling; utveckling av läkemedel; FoU; affärsmodell; innovation; stängd innovation; öppen innovation; entreprenörskap; immaterialrätt; beslutsfattande; osäkerhet; go no-go; go no-go recycle; företag; små och medelstora företag;

    Sammanfattning : Over the past century, the pharmaceutical industry has been a major contributor of individual and population health and societal wealth. Its products and services have contributed to longevity of large groups of patients and symptom relief from major diseases. LÄS MER

  4. 3. Centrifugal microfluidics-based point of care diagnostics at resource limited settings

    Författare :Ahmad Saleem Akhtar; Aman Russom; Ines Fernandes Pinto; Nicole Pamme; KTH; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; microfluidics; centrifugal microfluidics; point-of-care; low-cost; diagnostics; agarose beads; immunoassays; colorimetry; fluorescence; cytokines; nucleic acid amplification; isothermal amplification; COVID-19; portable; smartphone; resource limited settings.; Biotechnology; Bioteknologi;

    Sammanfattning : Advancements in medical diagnostics have allowed us to understand the underlying mechanism and treat the root cause for many diseases which had been causing morbidity and mortality up until this point in human history. Furthermore, many of the standard diagnostic procedures have now been transformed to provide answers at or near the point-of-care. LÄS MER

  5. 4. Modeling environment effects on spectroscopic properties of biomarkers and catalytic mechanisms in enzymes

    Författare :Camilla Gustafsson; Patrick Norman; Daniel Escudero; KTH; []
    Nyckelord :Computational chemistry; spectroscopy; biocatalysis; water flow; biomarkers; Teoretisk kemi och biologi; Theoretical Chemistry and Biology;

    Sammanfattning : Arguably, humans are in need of both better diagnostic tools to prevent pro- gression of diseases as well as greener catalysts for synthesis of chemicals.Neurodegenerative diseases affecting neurons in the brain leads to demen- tias, where Alzheimer’s disease (AD) is the most prevalent. LÄS MER

  7. 5. Mechanisms regulating Natural Killer Cell Cytotoxicity

    Författare :Hanna van Ooijen; Björn Önfelt; Karl-Johan Malmberg; Karolin Guldevall; Morgan Huse; KTH; []
    Nyckelord :NATURVETENSKAP; NATURAL SCIENCES; Natural Killer cell; Live-cell microscopy; Single cell; 3D; Microwell;

    Sammanfattning : Over the last 50 years, cancer survival rates have steadily improved thanks to earlier detection and novel treatment regimens. For example, drugs that act on the immune system, so-called immunotherapy, have drastically increased the prospect of survival for patients suffering from some of the most aggressive cancer types including advanced malignant melanoma. LÄS MER